I. Getov

发表

Physician's knowledge and experience with the off-label use of medicines

E. Naseva, M. Drenska, I. Getov, 2020 .

The off-label use of medicines in pediatric outpatients in Bulgaria based on an analysis of their prescription data

E. Naseva, M. Drenska, I. Getov, 2019, Drugs & Therapy Perspectives.

The knowledge and experience with the off-label use – results of a survey

E. Naseva, M. Drenska, I. Getov, 2019 .

Descriptive study for look-alike and sound-alike medicines based on local language peculiarities

H. Lebanova, I. Getov, E. Grigorov, 2012 .

Cross-Sectional Analysis of Current State of Arts and Community Pharmacists' Attitudes toward Value-Added Pharmacy Services in Bulgaria

J. Simeonova, I. Getov, Stefan Balkanski, 2019 .

Risk-Minimization Measures in the EU: Review of Two Year Period Safety Referral Procedures

I. Getov, V. Getova, 2020 .

PILOT STUDY ON THE IMPACT OF MEDICINES ADVERTISING ON HEALTHCARE PROFESSIONALS AND PATIENTS

H. Lebanova, I. Getov, E. Grigorov, 2015 .

Safety Assessment of Newly Marketed Herbal Medicines—Methodological Approach (Ginkgo biloba Example in Bulgaria)

G. Petrova, I. Getov, A. T. Tzenova, 2008, Journal of herbal pharmacotherapy.

Pilot study for total cholesterol measurement among patients with IHD at community pharmacies in Sofia.

E. Naseva, H. Lebanova, I. Getov, 2012 .

Pilot Study of Pharmacists' Attitudes towards and Expectations for Remuneration of Valueadded Pharmacy Services (VAPS) in Bulgaria.

J. Simeonova, I. Getov, Stefan Balkanski, 2020, Folia medica.

COST ASSESSMENT AND EXAMPLE APPROACH TO DEEP VENOUS THROMBOSIS TREATMENT

I. Getov, Tzvetan Kremenski, K. Girov, 2003 .

Study of the antibiotic prescription practice for safety purposes for inpatients hospitalized due to pneumonia

I. Getov, Natalia Radeva-Dafinova, M. Velikov, 2010 .

Ailanthus altissima (Mill.) Swingle - a terrible invasive pest in Bulgaria or potential useful medicinal plant?

H. Lebanova, I. Getov, N. Benbassat, 2014 .

AD HOC STUDY OF THE ROLE OF HOSPITAL PHARMACISTS IN CLINICAL TRIALS IN BULGARIA

I. Getov, E. Grigorov, V. Belcheva, 2014 .

Patients’ attitude about generics – Bulgarian perspective

H. Lebanova, I. Getov, Dimitar K. Manolov, 2012 .

Ethical Aspects of Vulnerable Group of Patients in Clinical Trials

H. Lebanova, I. Getov, E. Ivanova, 2017 .

Descriptive study of contemporary status of the traditional knowledge on medicinal plants in Bulgaria

Julia E. Napier, E. Kozuharova, H. Lebanova, 2013 .

Study of clinical experience with different approaches to controlled ovarian hyperstimulation: a focus on safety and efficacy

E. Naseva, T. Timeva, H. Lebanova, 2019, European journal of hospital pharmacy : science and practice.

Study of pharmacy students` attitudes for scientific researches and/or academic career in Bulgaria

I. Getov, E. Grigorov, V. Belcheva, 2015 .

What does self-medication counseling in Bulgarian community pharmacies look like – a field study

E. Naseva, H. Lebanova, I. Getov, 2020 .

Low dose treatment with methotrexate-adverse drug reactions survey.

V. Petkova, Z. Dimitrova, I. Getov, 2000, Bollettino chimico farmaceutico.

Relevance of pharmaceutical higher education to the labor market: a study of pharmacists' attitudes

D. Ivanova, T. Naydenov, A. Kerekovska, 2014 .

Psychotropic drugs in Bulgaria-frequency and risk of adverse drug reactions.

V. Petkova, Z. Dimitrova, I. Getov, 2002, Bollettino chimico farmaceutico.

The off-label use of medicines in pediatric outpatients in Bulgaria based on an analysis of their prescription data

E. Naseva, M. Drenska, I. Getov, 2019, Drugs & Therapy Perspectives.

Model Pharmacoeconomic Study on Iressa® (Gefitinib) as a First Line Treatment of Non-Small Cell Lung Cancer at Stage IIIB/IV in EGFR Mutation Positive Bulgarian Patients

E. Naseva, I. Getov, E. Grigorov, 2013 .

Analysis of primary outpatient data for off-label use of medicines in neurology

E. Naseva, M. Drenska, I. Getov, 2019 .

PATIENT REPORTING OF ADVERSE DRUG EVENTS - A NARRATIVE REVIEW

H. Lebanova, I. Getov, 2014 .

Safety limitations of fluoroquinolones’ use

I. Getov, 2020 .

Marketing authorization procedures with negative opinion from EMA—tendencies and novelties in 2021–2022

I. Getov, Violeta Getova-Kolarova, 2022, Annual for Hospital Pharmacy.

Calculating the cost for drug treatment including the adverse drug reactions treatment cost (primer for fentanyl TTS in Bulgaria).

G. Petrova, I. Getov, 2002, Bollettino chimico farmaceutico.

Physicians' knowledge and attitude towards adverse event reporting system and result to intervention--randomized nested trial among Bulgarian physicians.

E. Naseva, H. Lebanova, I. Getov, 2013, Medicinski glasnik : official publication of the Medical Association of Zenica-Doboj Canton, Bosnia and Herzegovina.

E-Detailing: Keyways for Successful Implementation of Digital Technologies in the Pharmaceutical Marketing

I. Getov, Stefan Balkanski, 2019, Promotion and Marketing Communications.

Study on consumers' preferences and habits for over-the-counter analgesics use.

I. Getov, A. Lefterova, 2004, Central European Journal of Public Health.

Testing willingness to pay for blood pressure measurement in community pharmacy

E. Naseva, H. Lebanova, I. Getov, 2012 .

Evaluation of the current status of the value-added pharmacy services and pharmacists’ attitude in Bulgaria

J. Simeonova, I. Getov, Stefan Balkanski, 2019, Pharmacia.

In-depth Assessment after 18 Months of Distance E-learning of Pharmacists in Bulgaria

H. Lebanova, I. Getov, E. Grigorov, 2021, Archives Of Pharmacy Practice.

Practical tool to assess reliability of web-based medicines information.

Ilko Getov, Hristina Lebanova, Evgeni Grigorov, 2014, Medicinski glasnik : official publication of the Medical Association of Zenica-Doboj Canton, Bosnia and Herzegovina.